Inhibitory effect of reversible serine protease inhibitors on the activity of cytotoxic T lymphocytes.
Arakawa
K
K
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Nakajima
H
H
Yoshida
T
T
Yasumura
T
T
Aikawa
I
I
Ohmori
Y
Y
Oka
T
T
D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004952:Esters; D016670:Gabexate; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D011480:Protease Inhibitors / Q000494:pharmacology*; D015842:Serine Proteinase Inhibitors; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects* / Q000276:immunology
D004952:Esters; D006146:Guanidines; D011480:Protease Inhibitors; D015842:Serine Proteinase Inhibitors; C034532:camostat; D016670:Gabexate